New statement outlines essentials of heart failure clinics

December 11, 2008

Philadelphia, 11 December 2008 - Heart failure (HF) clinics are an increasingly important approach to the treatment of patients with heart failure, yet there have been no published standards regarding the care provided by these specialized clinics. To address this gap, the Quality of Care Committee of the Heart Failure Society of America (HFSA) has developed a consensus statement summarizing the rationale, goals, and components of HF clinic care. The statement appears in the December issue of the Journal of Cardiac Failure (http://www.onlinejcf.com/), published by Elsevier.

Based on analysis of the best available research by an expert panel, the statement helps to define the structure and process of care provided by HF clinics. "The goals of the HF clinic are to reduce mortality and rehospitalization rates and improve quality of life for HF patients through individualized patient care," write the Committee members, led by Paul J. Hauptman, M.D., of Saint Louis University School of Medicine.

The statement defines "a family of 11 domains of care" provided by HF clinics, outlining specific components of care in each domain. For example, in the domain of Disease Management, the statement highlights the HF clinic's role in providing comprehensive education and counseling for patients and their families or caregivers, with the aim of promoting self-care.

Disease management also encompasses efforts to ensure that patients receive optimal medical therapy, appropriate follow-up, and assistance with social and financial concerns. A provider-to-patient ratio enabling individualized care and an infrastructure that allows for integration and coordination of care are also essential components of the HF clinic approach.

Other domains include Functional Status Assessment and Quality of Life Assessment. In these areas, the statement outlines essential tests and tools used to evaluate patients' health and functioning. In the Medical Therapy and Drug Evaluation domain, the goal is to ensure that treatment is consistent with current evidence-based guidelines, including systems for reviewing medications and for identifying patients who are not receiving optimal therapy. A similar process applies to Device Evaluation, reflecting the growing use of medical devices in patients with heart failure.

The statement also includes detailed information on the domains of Nutritional Assessment, Follow-Up, Advance Planning, Communication, Provider Education, and Quality Assessment in HF clinic care. "The 'HF clinic' has become a vital element in comprehensive care of the patient with HF," Dr. Hauptman and colleagues write. The Committee hopes the new statement will promote an appreciation of the essential features of the HF clinic approach, and its potential to improve patient outcomes.

"The management of heart failure has become both more complex and more successful," comments Barry M. Massie, M.D., Editor-in-Chief of Journal of Cardiac Failure. "Multidisciplinary clinics and programs can play an important role, both at the onset of this condition and in its more advanced stages. This document provides an outstanding overview of the rationale and goals of the heart failure clinic, as well as very practical guidance on how to organize and implement such a program."
-end-
About Journal of Cardiac Failure

Journal of Cardiac Failure (http://www.onlinejcf.com/) publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure--pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment. Journal of Cardiac Failure is the official journal of the Heart Failure Society of America and the Japanese Heart Failure Society. It has an Impact Factor of 3.067 (the highest among journals with a heart failure focus and 19th among all cardiovascular journals) and an Immediacy Factor of 1.306, the 7th among all cardiovascular journals.

About the Heart Failure Society of America

The Heart Failure Society of America (HFSA) is a nonprofit educational organization, founded in 1994 as the first organized association of heart failure experts. Today HFSA has over 1,700 members and provides a forum for all those interested in heart function, heart failure research and patient care. The Society also serves as a resource for governmental agencies (FDA, NIH, NHLBI, CMS). Additional information on HFSA can be found at www.hfsa.org.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Elsevier

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.